Skip to main content
. Author manuscript; available in PMC: 2007 Dec 1.
Published in final edited form as: Am J Clin Nutr. 2007 Jan;85(1):209–217. doi: 10.1093/ajcn/85.1.209

TABLE 1.

Distribution of study characteristics in the control subjects according to quartile (Q) of serum selenium1

Serum selenium
Q1 (50.5 to < 126.8) (n = 219) Q2 (≥ 126.8 to < 141.9) (n = 220) Q3 (≥ 141.9 to < 158.0) (n = 220) Q4 (≥ 158.0 to 253.0) (n = 220) P for trend
Median (ng/mL) 113.7 135.3 149.4 170.4
Age (y) 64.8 ± 1.42 64.7 ± 1.4 64.7 ± 1.4 64.7 ± 1.4 0.34
Prostate cancer screens (no./y)3 0.95 ± 0.1 0.97 ± 0.1 0.96 ± 0.1 0.95 ± 0.1 0.79
Family history of prostate cancer (%) 6.2 3.6 5.0 7.6 0.45
Some college-level education (%) 75.7 78.1 70.2 77.3 0.82
BMI (kg/m2) 27.8 ± 3.9 27.4 ± 3.9 27.2 ± 3.9 27.2 ± 3.9 0.07
Vigorous physical activity ≥ 1 h/wk (%) 67.5 70.5 68.6 70.9 0.56
Aspirin use ≥ 1 times/wk (%) 47.3 44.7 47.0 50.4 0.45
Ibuprofen use ≥ 1 times/wk (%) 16.0 10.8 12.4 15.9 0.91
Smoking status (%)
 Never 34.1 24.2 33.2 32.8 0.73
 Current 8.7 11.2 7.9 7.7 0.46
 Former 47.5 53.2 49.6 54.0 0.30
 Pipe and cigar (never cigarettes) 9.7 11.4 9.3 5.6 0.11
Alcohol use ≥ 15 g/d (%) 33.5 33.6 30.9 27.9 0.17
Energy (kcal/d) 2380 ± 930 2409 ± 928 2385 ± 928 2228 ± 916 0.09
Total fat (g/d) 79.6 ± 17.2 78.4 ± 17.1 80.9 ± 16.9 78.1 ± 17.3 0.70
Fruit (servings/d) 3.4 ± 2.2 3.5 ± 2.2 3.5 ± 2.2 3.7 ± 2.2 0.08
Vegetables (servings/d) 5.4 ± 2.0 5.5 ± 2.0 5.3 ± 2.0 5.7 ± 2.0 0.46
Red meat intake (g/d) 103.2 ± 58.1 97.7 ± 58.0 98.1 ± 57.3 91.7 ± 58.5 0.06
Dietary lycopene (μg/d) 11 166 ± 6137 11 594 ± 6127 11 424 ± 6048 11 631 ± 6181 0.51
Dietary β -carotene (μg/d) 5041 ± 2576 4980 ± 2572 4942 ± 2539 5351 ± 2594 0.27
Total vitamin E intake (IU/d) 128 ± 242 141 ± 242 153 ± 239 198 ± 244 0.004
Calcium (mg/d) 1171 ± 452 1176 ± 452 1188 ± 446 1180 ± 456 0.79
1

All values other than age were standardized for age and study center. Total fat, fruit, vegetables, red meat, dietary lycopene, dietary β-carotene, total vitamin E, and calcium intakes were also standardized for energy intake.

2

± SE (all such values).

3

Average number of prostate cancer screening examinations (prostate-specific antigen, digital rectal examination, or both) from enrollment until the year of diagnosis (cases) or until the study year in which a control was selected. Maximal period is limited to period of active screening (years 0–5).